_ HOUSTON, December. 19, 2007 (PRIMe newsWIRE) — Encysive product Inc. (nasdaq:ENCY) announce the fact that today it received delisting warning a letter of D nasdaq stock market, notifying it that D company closing cost per portion for its generally stock its under D $1,00 minimum offer price for 30 in the following trading day _ consequently, Encysive do not meet any longer nasdaq’s continue listing criterion and has 180 calendars day, or to June 16, 2008, to recover observance _ during this 180-day period, Encysive portion becomes to continue to act at D nasdaq.
_ _ to recover observance, D closing price by D company stock must to remain general at or over $1.00 for a minimum of 10 in the following business day before D end of D 180 calendars do not offer day observance period _ to D company be able to also be suitably for additionally 180 calendars a day observance period by transfer ring D nasdaq main market _ if D company to recover observance end of D observance period (or any extension of it) and to select too not fallen nasdaq’s decision too delist to be generally stock, Encysive’s general stock become its delisted of nasdaq.
_ _ over Encysive product
_ Encysive product Inc. its global biopharmaceutical company engage molecule in D discovery, development and commercialization of novel, synthetically, small build up to address unmet medically need _ our research and development program its predominantly focused on D treatment and prevention of interrelated illness of D container endothelium and use our expertise in D range from D intravascular inflammatory process, refer like D inflammatory cascade, and container illness _ to learn more over Encysive product please visits our web site: _ www.encysive.com.
_ _ D Encysive product Inc. trade mark its available at http://www.primenewswire.com/newsroom/prs/?pkgid=843
_ this it operate release contained “forward — look statement” within D meaning of section 27A of D security function from 1933, how change, and section 21E of D security exchanges functions from 1934, as changes _ this forward — look statement its dependent on determines danger, bends and uncertainty that cause result to actually differentiate materially of jen to project _ under jen danger, bends and uncertainty can to be: _ D probability that ours generally stock act in distance to remain acceptable register on nasdaq; _ D possibility of its suitably for additionally time to recover observance; _ D effect of any delisting of ours generally stock, as well as more specifically danger, to bend and uncertainty verge Encysive as jen specify in its report on form 8-K, 10-Q and 10-K arrange with D STATE OF security and exchange commission _ given this danger, bend and uncertainty, any or all from this forward — statement can to be examined to have wrongly _ therefore you look not be supposed not to build for possibly such forward — to look statement _ in addition, Encysive take up no task to updates or improve this forward — statement _ D look privately security law case improve function from 1995 make possible this discussion.
_ _ IN CONNECTION STEPPING: _ Encysive product investors: _ ann Tanabe, VP, investor relation and korporativ communication (713) 796-8822 BMC communication means: _ Dan Budwick (212) 477-9007 Ext.. _ 14 D Forelle group of Marcy Strickler (646) 378-2927
_. _
source
bookmark this post:
Related articles:
Nasdaq smash from Intel
TD mutual funds report December net turnovers
_ SNAPSHOT MARKET: _ fall STATE stocks like investors question as useful to draw in can be
The Must Stop now Private Business.
Zevotek, Inc. develops relationship to buying order finance the company
